Revvity, Inc.
RVTY
157.02−1.23 (−0.78%)Nov 12, 7:00 PM ET
Key stats
- Open
- 156.51
- Day high
- 159.36
- Day low
- 153.04
- Previous close
- 158.25
- Volume
- 1.47M
- VWAP
- 157.24
- 52-week high
- 171.74
- 52-week low
- 81.22
- Market cap
- 17.67B
- Shares out
- 111.59M
- Employees
- 11,000
- Listed
- 1972
About Revvity, Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
LABORATORY ANALYTICAL INSTRUMENTS · WALTHAM, MA · revvity.com
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 4.2K
- Put open interest
- 4.5K
- Put/call
- 1.07
- At-the-money IV
- 68.4%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 155 call | 8.90 | Nov 10, 3:14 PM | 166 | 166 | 68.4% |
| 130 put | 1.15 | Nov 10, 11:15 AM | 112 | 492 | 97.8% |
| 165 put | 10.30 | Nov 10, 11:29 AM | 80 | 79 | 56.9% |
| 145 put | 1.65 | Nov 11, 9:44 AM | 19 | 1.1K | 79.3% |
| 125 put | 0.36 | Nov 4, 10:00 AM | 9 | 105 | 103.4% |
| 150 put | 2.52 | Nov 9, 2:31 PM | 9 | 834 | 72.6% |
Quarterly results
Massive · Nov 10, 2026| Q3 2026 to Oct 4, 2026 | Q2 2026 to Jul 5, 2026 | Q1 2026 to Apr 5, 2026 | Q4 2025 to Dec 28, 2025 | |
|---|---|---|---|---|
| Revenue | $728.90M | $729.69M | $711.12M | $772.06M |
| Gross profit | $418.58M | $416.87M | $387.65M | $421.66M |
| Operating income | $95.14M | $89.32M | $75.89M | $111.75M |
| Net income | $62.30M | $51.82M | $40.72M | $98.36M |
| Diluted EPS | 0.56 | 0.47 | 0.36 | 0.87 |
| Operating cash flow | $166.70M | $191.94M | $115.23M | $181.96M |
| Assets | $11.49B | $12.05B | $12.00B | $12.17B |
| Liabilities | $4.22B | $4.82B | $4.81B | $4.92B |
| Equity | $7.27B | $7.23B | $7.18B | $7.25B |
Technicals
Massive · Nov 12, 2026- 50-day average149.92
- 200-day average113.80
- RSI (14 days)51.8
Short interest
Massive · Oct 30, 2026- Oct 30, 20266.53M shares · 3.9 days to cover
- Oct 15, 20266.39M shares · 3.6 days to cover
- Sep 30, 20266.30M shares · 2.4 days to cover
- Sep 15, 20266.22M shares · 3.2 days to cover
Dividends
Massive · Jan 22, 2027- Ex Jan 22, 2027, paid Feb 12, 20270.0700 · 4 a year
- Ex Oct 23, 2026, paid Nov 13, 20260.0700 · 4 a year
- Ex Jul 17, 2026, paid Aug 7, 20260.0700 · 4 a year
- Ex Apr 17, 2026, paid May 8, 20260.0700 · 4 a year
- Ex Jan 16, 2026, paid Feb 6, 20260.0700 · 4 a year
- Ex Oct 17, 2025, paid Nov 7, 20250.0700 · 4 a year
- Ex Jul 18, 2025, paid Aug 8, 20250.0700 · 4 a year
- Ex Apr 17, 2025, paid May 9, 20250.0700 · 4 a year
Related companies
MassiveNews coverage
No stories about Revvity, Inc. right now.